GJ
Geeta Jitesh Tak
About Geeta Jitesh Tak
Geeta Jitesh Tak has 5 years in corporate governance. Holds Director and Company Secretary roles. Currently with 2 companies, including Shrikrishna Pharma Foils India Private Limited and Steribio Lifesciences Private Limited. Formerly with 1 company, such as Nutrifresh Farm Tech India Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Shrikrishna Pharma Foils India Private Limited
U27203MH2021PTC364042
|
Director | 16 Jul 2021 | 2021 | Active |
|
Steribio Lifesciences Private Limited
U24246MH2022PTC389085
|
Company Secretary | 31 Mar 2025 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nutrifresh Farm Tech India Private Limited
U51909PN2019PTC188626
|
Company Secretary | 15 Feb 2023 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Geeta Jitesh Tak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geeta Jitesh Tak
Geeta Jitesh Tak has 5 years in corporate governance. Holds Director and Company Secretary roles. Currently with 2 companies, including Shrikrishna Pharma Foils India Private Limited and Steribio Lifesciences Private Limited. Formerly with 1 company, such as Nutrifresh Farm Tech India Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Geeta Jitesh Tak is associated with 2 companies as Director and Company Secretary.
Geeta Jitesh Tak has expertise in General Business, Technology.
Geeta Jitesh Tak has 5 years in corporate governance.